NLRP3 and neoplasm: The effects of SCFA, an inhibitor of histone deacetylase, have been shown in Caco-2 tumor cells that have been stimulated with LPS to suppress expression of all NLRP3 components, attenuate intestinal barrier dysfunction, inhibit ROS generation, and activate autophagy (207).